42 Followers on Owler

Innovent Biologics

engages in research and development of monoclonal antibody drugs for cancer and autoimmune diseases... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights

Innovent Biologics

engages in research and development of monoclonal antibody drugs for cancer and autoimmune diseases... Read more
Innovent Biologics Chairman & CEO: Michael Yu

Chairman & CEO

Michael Yu

CEO Approval Rating

90/100

2011

PublicHong Kong Stock Exchange1801

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
28342836 NAICS listing

Annual Revenue
$3.5B
Employees
4,872
Funding
$1.3B
Investments
1

News

Conference Presentation
Jan 16, 2025
PR Newswire
Innovent Presents at the 43rd Annual J.P. Morgan Healthcare Conference
Partnership
Dec 17, 2024
Pharmabiz
Innovent Biologics and Lilly expand collaboration agreement to commercialize BTK inhibitor, Jaypirca in Mainland China

Innovent Biologics Competitors

1Sino Biological
2BeiGene
3Mabworks
4Brii Bio
5Connect Biopharma
6EMD Serono
7TESARO
8Alphamab Oncology
9Immatics
10Lepu
Unlock 12 + competitors

Trending Companies